Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 10-2024 | 10-2023 | 10-2022 | 10-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,239 | -23,652 | -28,913 | -18,970 | -5,540 |
| Depreciation Amortization | 245 | 397 | 330 | 342 | 213 |
| Income taxes - deferred | -50 | N/A | N/A | N/A | N/A |
| Accounts receivable | 125 | 413 | 170 | -152 | -71 |
| Other Working Capital | 1,240 | 8,200 | 3,697 | 2,289 | 412 |
| Other Operating Activity | 1,893 | 759 | 2,222 | 5,288 | -456 |
| Operating Cash Flow | $-7,787 | $-13,883 | $-22,493 | $-11,203 | $-5,443 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 18 | N/A | -74 | -256 | -14 |
| Sale Of Investment | N/A | 8,143 | 39,270 | -35,733 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -13,384 | N/A | N/A |
| Other Investing Activity | 0 | 26 | -13,410 | -10 | -168 |
| Investing Cash Flow | $18 | $8,169 | $25,787 | $-35,998 | $-182 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,644 | N/A | N/A | N/A | N/A |
| Debt Issued | 879 | N/A | N/A | N/A | -9 |
| Common Stock Issued | 178 | 3,655 | N/A | 28,361 | 23,783 |
| Other Financing Activity | -34 | 68 | 373 | 120 | 879 |
| Financing Cash Flow | $3,666 | $3,723 | $373 | $28,481 | $24,652 |
| Beginning Cash Position | 4,292 | 6,408 | 2,800 | 21,653 | 3,141 |
| End Cash Position | 189 | 4,417 | 6,466 | 2,933 | 22,168 |
| Net Cash Flow | $-4,103 | $-1,991 | $3,667 | $-18,719 | $19,027 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,787 | -13,883 | -22,493 | -11,203 | -5,443 |
| Capital Expenditure | N/A | N/A | -74 | -256 | -14 |
| Free Cash Flow | -7,787 | -13,883 | -22,567 | -11,458 | -5,457 |